Skip to content

Evaluation of Herbal Chewable tablet in Orthodontic patients

Evaluation of Anti plaque effect of a novel herbal chewable tablet containing orange peel and syzygium cumini extract in patients undergoing orthodontic therapy : A Randomised controlled trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090051
Enrollment
111
Registered
2025-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K038- Other specified diseases of hard tissues of teeth

Interventions

Intervention1: Herbal dispersible chewable tablet: containing orange peel and syzygium cumini extract 10 ml twice daily Control Intervention1: chlorhexidine mouthwash: 0.12% chlorhexidine mouthwash 1

Sponsors

self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged 17-25 years undergoing fixed orthodontic therapy. 2. Patients with no history of systemic diseases affecting oral health. 3. Willingness to comply with study protocol. 4. Patients undergoing fixed orthoodntics

Exclusion criteria

Exclusion criteria: 1. History of periodontal therapy in the past 6 months. 2. Known allergies to Citrus or Herbal extracts. 3. Use of antibiotics or anti-inflammatory medications in the past month.

Design outcomes

Primary

MeasureTime frame
Reduction in plaque index scores (Silness and L e plaque index), Changes in gingival index (L e and Silness), The Orthodontic Plaque Index(OPI) An oral hygiene index for patients with multibracket appliances.Timepoint: 0,3,5,12 days

Secondary

MeasureTime frame
reported acceptability and compliance, and any adverse effects.Timepoint: 12 days

Countries

India

Contacts

Public ContactDr. Surekha Rathod

Rnajeet Deshmukh Dental College, Nagpur

drsurekhar@gmail.com09011071477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026